dilactide has been researched along with docetaxel anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; Liu, J; Shu, M; Su, M; Xie, J; Zeng, Q | 1 |
| Chen, H; Lin, Y; Xie, B; Zhuang, X | 1 |
| Baruah, M; Garnaik, B; Giram, P; Khandwekar, A; Koratkar, S; Sharma, N; Shitole, AA | 1 |
3 other study(ies) available for dilactide and docetaxel anhydrous
| Article | Year |
|---|---|
Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dioxanes; Docetaxel; Drug Carriers; Drug Compounding; Female; Folic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2020 |
Enhanced Antitumor Efficacy of Docetaxel-Loaded Monomethoxy Poly(ethylene glycol)-Poly(D, L-lactide-co-glycolide) Amphiphilic Copolymer Against Non-Small Cell Lung Cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dioxanes; Docetaxel; Drug Carriers; Humans; Lung Neoplasms; Nanoparticles; Polyethylene Glycols | 2020 |
LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dioxanes; Docetaxel; Drug Carriers; Gonadotropin-Releasing Hormone; Humans; Male; Nanocapsules; Nanoparticles; Polyethylene Glycols; Prostatic Neoplasms; Quercetin | 2020 |